PharmaShots | Incisive News in 3 Shots

Subscribe Now

India Samsung Bioepis

Samsung Bioepis Initiates Recruitment of Patients in P-III Study for SB12 (biosimilar- eculizumab) to Treat Paroxysmal Nocturnal Hemoglobinuria (PNH) in India

Samsung Bioepis Initiates Recruitment of Patients in P-III Study for SB12 (biosimilar- eculizumab) to Treat Paroxysmal Nocturnal H...

August 16, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us